Beyond all the side effects outlined above, there's one specific concern that metformin users may encounter, which could ...

Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

Like any medication, metformin can interact with other drugs you might be taking. If you're a woman, this one interaction in particular may be of concern.

A woman in her 50s came into the emergency department at Oneida Health with chest pain. She has diabetes, high blood pressure ...

Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...

The prescription of metformin was associated neither with the development of age-related macular degeneration (AMD) in participants without the condition nor with progression to advanced forms of the ...

Metformin, long trusted for diabetes, turns out to work in the brain too. By shutting down Rap1 in the hypothalamus, the drug lowers blood sugar more effectively than previously understood, opening ...

Metformin, the world’s most widely used diabetes drug, has long been recognized for its surprising range of benefits beyond lowering blood sugar, from reducing inflammation to lowering cancer risk.

Metformin vs. Ozempic: What’s the Difference? Metformin (Fortamet, Glumetza) and semaglutide (Ozempic, Rybelsus) are medicines that treat type 2 diabetes. They both lower blood sugar, but they work ...

In a recent study published in the journal Science Advances, researchers tested whether low, clinically relevant doses of metformin lower blood glucose via inhibition of Ras-related protein 1 (Rap1) ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works. Scientists at Baylor College of ...

Metformin use in mCRC patients improved PFS during first-line 5-fluorouracil-based chemotherapy, but no OS benefit was observed. The study suggests metformin's potential as an adjunct therapy in mCRC, ...